SlideShare a Scribd company logo
1 of 40
Organophosphate poisoning
(Ops)
A CASE AND ARTICLE PRESENTATION ON
Examples
Examples of organophosphates include:
- insecticides (malathion, parathion, diazinon,
fenthion, dichlorvos, chlorpyrifos, ethion)
- nerve gases (soman, sarin, tabun, VX)
- ophthalmic agents (echothiophate,
isoflurophate)
- antihelmintics (trichlorfon).
- Herbicides (tribufos [DEF], merphos) are
tricresyl phosphate–containing industrial
chemicals.
Frequency
Organophosphate compounds were first
synthesized in the early 1800 when Lassaigne
reacted alcohol with phosphoric acid.
Shortly thereafter in 1854, Philip de Clermount
described the synthesis of tetraethyl
pyrophosphate at a meeting of the French
Academy of Sciences.
Eighty years later, Lange, in Berlin, and,
Schrader, a chemist at Bayer AG, Germany,
investigated the use of organophosphates as
insecticides.
History
COVALENT BOND
AGING
MECHANISM OF ACTION OF
ORGANOPHOSPATE POISONING
9
PHYSIOLOGY REVISITED
11
Inhalation
• Cough
• Difficulty in breathing
• Bronchitis
• Pneumonia
Eye contact
• Irritation
• Pain
• Lacrimation
• Miosis
• Blurring vision
• Photophobia
clinical features
depends on route of entry
ingestion inhalation eye contact
GASTRIC LAVAGE ACTIVATED CHARCOAL
OROPHARYNGEAL AIRWAY USED AMBU VENTILATION & ET TUBE
MANAGEMENT OF OP POISONING
NAME: Mr.Krishna reddy.
GENDER: MALE
AGE: 33 years
DEPARTMENT: General Medicine (male medical (IV)
DATE OF ADMISSION: 05-02-2015.
CHIEF COMPLAINTS:
Vomiting present – 5 episodes.
Burning sensation of throat and abdomen.
HISTORY OF PRESENT ILLNESS: No h/o swelling neck and micturation
present
DEMOGRAPHIC DETAILS
FAMILY HISTORY: Not relevant
GENERAL EXAMINATION:
PHYSICAL EXAMINATION:
Conscious and oriented
TEMP : Afebrile
BP : 130/90 mm Hg
PULSE : 124 bpm
SYSTEMS EXAMINATION:
CVS : S1, S2 (+)
CNS : pupils-NSRL+
RS : BLAE +
RR :16 cpm.
P/A : soft.
PAST MEDICAL HISTORY:
not a K/c/o Diabetic, Hypertensive, Epileptic, TB.
PERSONAL HISTORY AND HABITS:
known alcoholic, and not a smoker.
FAMILY HISTORY:
Nothing is relevant.
PAST SURGICAL HISTORY:
No h/o previous surgery.
PROVISIONAL DIAGNOSIS: An alleged case of
op poisoning @
7.30p.m near Badvel.
ASSESSMENT
ORGANOPHOSPHORUS COMPOUND POISONING
DRUG CHART
S.no DRUGS GENERIC NAME INDICATION DOSE ROA FREQUENCY DURATION
1. Inj. Atropine Atropine Antidote(anti
cholinergic)
2mg
(amp)
IV TID 5/2/115 to
12/2/15
2. Inj. PAM Pralidoxime Antidote 1 gm
(amp)
IV BD 5/2/15 to
12/2/15
3. IVF Intravenous
fluids
Electrolyte
balance
2 NS
2 RL
IV INFUSION
OD
9/2/15 to
12/2/15
4. Inj. Pantop Pantaprazole Anti ulcerative 40 mg IV BD 5/2/15 to
12/2/15
5. Inj. Ceftriaxone Ceftriaxone Antibacterial 1 g IV BD 5/2/15 to
9/2/15
Progress chart
PROGNOSIS TREATMENT
Day 1,
O/E, Pt-unconscious,vomiting BP-
130/90mmHg,PR-110bpm,RS-
BLAE+, P/A-soft, CNS-NSRL+
Rx, Inj. Atropine 2 amp-IV TID in 1 NS
Inj. Pantop 40mg IV BD
Inj. PAM 1gm IV BD
Inj. Ceftriaxone 1 gm IV BD
Inj. Ondansetron 4mg IV BD
Day 2, O/E, vomiting
Pt is conscious, coherent, pupils-
NSRL+
Rx, CST
stop Inj ondansetron
Day 3,O/E
Pt-c/c, BP-130/80mm/Hg, PR-
110bpm
Rx, CST
Progress chart….
Day 4 , O/E,
Pt- c/c, irritable, burning sensation,
pupils-B/L dilated, reacting to
light,BP-130/90mm Hg,PR-94bpm,
Rx, CST
Day 5,
Pt-c/c, ↓ irritability,BP-
110/70mmHg,pupils dilated, PR-
92bpm,
Rx, CST
IVF 2DNS, 1RL, 1NS
Day 6,
Pt-general condition is fair ,C/O
body pains , headache
Rx, CST
T.PCT 500mg BD
T. Cefixime 200 mg- P/O- BD
Day 7,
Pt- symptomatically, BP- 120/80
mm HG, PR-90bpm, CNS-NAD, RS-
Clear
Rx, CST
Progress chart…
Discharge medication:
Patient general condition is symptomatically better,
Rx,
T. B-Complex OD
T. Rantac 150mg BD
T. Amoxiclav 625mg BD
T.PCT 500mg TID
Asked to review after 1 week.
PHARMACIST INTERVENTIONS
Possible drug- drug interactions: No specific drug interactions
were observed.
Possible ADRs are:
Atropine:
Dry mouth, dysphagia, constipation, flushing, dryness of skin,
palpitations
Ceftriaxone:
super infection, rash, fever, pruritis, nephrotoxicity
Amoxyclav:
GI disturbances, anaphylactic shock, pruritis, skin rashes
PATIENT COUNSELING
REGARDING DISEASE CONDITION :
Organophosphorus compound poisoning is a lethal one
if not treated with antidote immediately. The compound
may cause respiratory depression, bradycardia,
hypotension,
sweating(cholinergic),unconsciousness…etc
REGARDING DRUGS MEDICATION PROFILE:
Inj. Atropine: Anti cholinergic drug which act as
antidote for the poisoning
Inj. PAM (Pralidoxime): it is an antidote.
Inj. Ceftriaxone: antibacterial to treat hospital acquired
infections.
REGARDING LIFE STYLE MODIFICATIONS
 Advised family to support the patient by any means
 After knowing that poisoning occur ,water with mustard
or water with excess salt is given and vomiting should be
induced.
 Referred and counseled given by psychiatrist:
 The causes for suicidal attempts is to be analyzed based
on that counseling is done.
 To do meditation or yoga to relieve stress and to relax
well
 Advised him if any suicidal tendencies are seen in him, to
consult a psychiatrist immediately
TITLE
“ INCIDENCE AND ASSESSMENT OF ANTIDOTES IN OP
POISONING AT TERTIARY CARE HOSPITAL,
SOUTH INDIA”
Corresponding author:
Daghari Zakieh Jasem,
Nikitha,
Rajeswari Ramaswamy,
Arpan Dutta Roy,
Dr. Anjani M. Reddy
OP compounds and other pesticides are commonly used for
suicide.
 Globally, OP Poisoning is a major problem though its types
varies in different countries.
Organophosphate (OP) poisoning is always having high
morbidity and mortality rates, both in poor and in well-
developed countries.
INTRODUCTION
OP POISONING
Major cause of morbidity and mortality is due to self-
poisoning and because of their easy availability.
The causes of poisoning are many-civilian, industrial,
accidental & deliberate.
Since the exact causative agents is not known there is a
greater need for understanding the clinical characteristics of OP
Poisonings.
In the majority of situations there is a lack of analytical
assistance in most of the primary health care systems.
The physicians mostly depend on clinical signs and
symptoms for diagnosis.
 However, the toxicity might become irreversible or even
fatal because onset of symptoms may take some time to
develop.
The Purpose of the study was to find out the incidence of
OP (Organo Phosphate) poisoning cases in the ED (Emergency
Department), and to assess the antidotes.
METHODOLOGY
 Study design : A Prospective observational study.
 Study site :MVJ Medical College and Research Hospital,Bangalore.
 Study duration : The study carried out over for 6 months.
 Sample size : 90 op poisoning patients.
 Inclusion criteria : OP poisoning cases in Emergency Department
including casualty and ICU are included in the study.
 Exclusion criteria : All other poisoning, other than OP cases, were
excluded from the study.
METHODOLOGY………
STUDY MATERIALS:
 Patient demographic data collection form.
 Patient informed consent form.
 Case Report Form (CRF).
ANALYSIS
STATISTICAL ANALYSIS
All the cases included in the study, were analyzed for the reason
for Poisoning; appropriateness of gastric lavage, selection and
rational use of antidotes by the investigators, using Micromedex
database.
DATA ANALYSIS
The data including demographic information (age, sex), toxic
substances involved, type of poisoning, clinical symptoms,
laboratory tests and patient outcome were evaluated.
Necessary steps were taken to determine the impact of clinical
pharmacist involvement in poison management.
RESULTS AND DISCUSSION
CONCLUSION
There are considerable variations in the practice of gastric lavage
and antidote utilization in practicing clinicians in the study site.
In many cases the dosing interval was wrong which lead to
problems like Atropine induce Psychosis.
This Study would help in prompt and appropriate poisoning
treatment, and prevent the prolonged hospitalization & better
patient outcome.
Javeed case presentation op poisoning

More Related Content

What's hot

A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertensionDrMaheshGurajapu
 
Case presentation on Acute Ischemic stroke
Case presentation on Acute Ischemic strokeCase presentation on Acute Ischemic stroke
Case presentation on Acute Ischemic strokeMohammed Masiuddin
 
Case presentation on lower respiratory tract, hypertention
Case presentation on lower  respiratory tract, hypertentionCase presentation on lower  respiratory tract, hypertention
Case presentation on lower respiratory tract, hypertentionShahanibrahim
 
CASE PRESENTATION ON LEG CELLULITIS
CASE PRESENTATION ON LEG CELLULITISCASE PRESENTATION ON LEG CELLULITIS
CASE PRESENTATION ON LEG CELLULITISCHANDANAC24
 
Case presentation on multinodular goiter
Case presentation on multinodular goiterCase presentation on multinodular goiter
Case presentation on multinodular goiterSrisharikakumar
 
Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )
Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )
Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )Dr.Hashim Syed Ali (Dr.Foster)
 
Benign Prostatic Hyperplasia (Surgical Case Presentation)
Benign Prostatic Hyperplasia (Surgical Case Presentation)Benign Prostatic Hyperplasia (Surgical Case Presentation)
Benign Prostatic Hyperplasia (Surgical Case Presentation)Dr. Aryan (Anish Dhakal)
 
Case study on peptic ulcer disease
Case study on peptic ulcer diseaseCase study on peptic ulcer disease
Case study on peptic ulcer diseasekrishna mathiyarasan
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer diseaseBasil Wilson
 
CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...
 CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc... CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...
CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...Dr. Darayus P. Gazder
 
Case presentation on hypothyroidism
Case presentation on hypothyroidismCase presentation on hypothyroidism
Case presentation on hypothyroidismDr. Shazia Afreen
 
CASE PRESENTATION ON CIRRHOSIS OF LIVER WITH PORTAL HYPERTENSION, HEPATIC EN...
CASE PRESENTATION ONCIRRHOSIS OF LIVER WITH PORTAL  HYPERTENSION, HEPATIC EN...CASE PRESENTATION ONCIRRHOSIS OF LIVER WITH PORTAL  HYPERTENSION, HEPATIC EN...
CASE PRESENTATION ON CIRRHOSIS OF LIVER WITH PORTAL HYPERTENSION, HEPATIC EN...Akhil Joseph
 
LIVER CIRRHOSIS
LIVER CIRRHOSISLIVER CIRRHOSIS
LIVER CIRRHOSISAnvy Anvia
 

What's hot (20)

A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertension
 
Case presentation on Acute Ischemic stroke
Case presentation on Acute Ischemic strokeCase presentation on Acute Ischemic stroke
Case presentation on Acute Ischemic stroke
 
case study on HYPOTHYROIDISM
case study on HYPOTHYROIDISMcase study on HYPOTHYROIDISM
case study on HYPOTHYROIDISM
 
Case presentation on lower respiratory tract, hypertention
Case presentation on lower  respiratory tract, hypertentionCase presentation on lower  respiratory tract, hypertention
Case presentation on lower respiratory tract, hypertention
 
CASE PRESENTATION ON LEG CELLULITIS
CASE PRESENTATION ON LEG CELLULITISCASE PRESENTATION ON LEG CELLULITIS
CASE PRESENTATION ON LEG CELLULITIS
 
Alcoholic Liver Disease
Alcoholic Liver DiseaseAlcoholic Liver Disease
Alcoholic Liver Disease
 
Case presentation on multinodular goiter
Case presentation on multinodular goiterCase presentation on multinodular goiter
Case presentation on multinodular goiter
 
Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )
Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )
Case presentation of COPD ( Chronic Obstructive Pulmonary Disease )
 
Benign Prostatic Hyperplasia (Surgical Case Presentation)
Benign Prostatic Hyperplasia (Surgical Case Presentation)Benign Prostatic Hyperplasia (Surgical Case Presentation)
Benign Prostatic Hyperplasia (Surgical Case Presentation)
 
case presentation on Osteoporosis
case presentation on  Osteoporosis case presentation on  Osteoporosis
case presentation on Osteoporosis
 
Case Presentation on Psoriasis
Case Presentation on PsoriasisCase Presentation on Psoriasis
Case Presentation on Psoriasis
 
Silico tuberculosis
Silico tuberculosisSilico tuberculosis
Silico tuberculosis
 
Case study on peptic ulcer disease
Case study on peptic ulcer diseaseCase study on peptic ulcer disease
Case study on peptic ulcer disease
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...
 CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc... CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...
CASE PRESENTATION : PYREXIA OF UNKNOWN ORIGIN / Hemophagocytic lymphohistioc...
 
Case presentation on hypothyroidism
Case presentation on hypothyroidismCase presentation on hypothyroidism
Case presentation on hypothyroidism
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
CASE PRESENTATION ON CIRRHOSIS OF LIVER WITH PORTAL HYPERTENSION, HEPATIC EN...
CASE PRESENTATION ONCIRRHOSIS OF LIVER WITH PORTAL  HYPERTENSION, HEPATIC EN...CASE PRESENTATION ONCIRRHOSIS OF LIVER WITH PORTAL  HYPERTENSION, HEPATIC EN...
CASE PRESENTATION ON CIRRHOSIS OF LIVER WITH PORTAL HYPERTENSION, HEPATIC EN...
 
LIVER CIRRHOSIS
LIVER CIRRHOSISLIVER CIRRHOSIS
LIVER CIRRHOSIS
 
A case study on uti
A case study on utiA case study on uti
A case study on uti
 

Similar to Javeed case presentation op poisoning

Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoningFatma Faris
 
Preclinical experimentation: An overview
Preclinical experimentation: An overviewPreclinical experimentation: An overview
Preclinical experimentation: An overviewSubhash Yende
 
Organophosporous Poisoning - Forensic Medicine
Organophosporous Poisoning - Forensic MedicineOrganophosporous Poisoning - Forensic Medicine
Organophosporous Poisoning - Forensic Medicinesuaveguava12
 
Organophosphate Poisoning - Update on Management
Organophosphate Poisoning  - Update on Management Organophosphate Poisoning  - Update on Management
Organophosphate Poisoning - Update on Management Anoop James
 
Dose-dependent hepatotoxicity effects of Zinc oxide nanoparticles
Dose-dependent hepatotoxicity effects of Zinc oxide nanoparticlesDose-dependent hepatotoxicity effects of Zinc oxide nanoparticles
Dose-dependent hepatotoxicity effects of Zinc oxide nanoparticlesNanomedicine Journal (NMJ)
 
Fish pharmacology Ashish sahu
Fish pharmacology Ashish sahuFish pharmacology Ashish sahu
Fish pharmacology Ashish sahuAshish sahu
 
QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND METHYL PARATHION P...
QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND  METHYL PARATHION P...QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND  METHYL PARATHION P...
QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND METHYL PARATHION P...IJSIT Editor
 
Organophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptxOrganophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptxbiplave karki
 
Mannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptxMannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptxRachel O
 
organophosphorous poisoning management in ICU
organophosphorous poisoning management in ICUorganophosphorous poisoning management in ICU
organophosphorous poisoning management in ICUintentdoc
 
Pharma intro by yousaf shah
Pharma intro by yousaf shahPharma intro by yousaf shah
Pharma intro by yousaf shahyousaf shah
 
Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...
Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...
Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...gynomark
 

Similar to Javeed case presentation op poisoning (20)

Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
UTI.pptx
UTI.pptxUTI.pptx
UTI.pptx
 
Pharma New-1.pdf
Pharma New-1.pdfPharma New-1.pdf
Pharma New-1.pdf
 
Preclinical experimentation: An overview
Preclinical experimentation: An overviewPreclinical experimentation: An overview
Preclinical experimentation: An overview
 
D.SRUTHI
D.SRUTHID.SRUTHI
D.SRUTHI
 
Organophosporous Poisoning - Forensic Medicine
Organophosporous Poisoning - Forensic MedicineOrganophosporous Poisoning - Forensic Medicine
Organophosporous Poisoning - Forensic Medicine
 
Organophosphate Poisoning - Update on Management
Organophosphate Poisoning  - Update on Management Organophosphate Poisoning  - Update on Management
Organophosphate Poisoning - Update on Management
 
Dose-dependent hepatotoxicity effects of Zinc oxide nanoparticles
Dose-dependent hepatotoxicity effects of Zinc oxide nanoparticlesDose-dependent hepatotoxicity effects of Zinc oxide nanoparticles
Dose-dependent hepatotoxicity effects of Zinc oxide nanoparticles
 
Fish pharmacology Ashish sahu
Fish pharmacology Ashish sahuFish pharmacology Ashish sahu
Fish pharmacology Ashish sahu
 
hello
hellohello
hello
 
QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND METHYL PARATHION P...
QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND  METHYL PARATHION P...QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND  METHYL PARATHION P...
QUALITATIVE AND QUANTITATIVE ANALYSIS OF FENVALERATE, AND METHYL PARATHION P...
 
Organophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptxOrganophosphorus_Poisoning_final.pptx
Organophosphorus_Poisoning_final.pptx
 
Mannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptxMannagement of organophosphate poisoning in the tropics.pptx
Mannagement of organophosphate poisoning in the tropics.pptx
 
omar 1st
omar 1stomar 1st
omar 1st
 
organophosphorous poisoning management in ICU
organophosphorous poisoning management in ICUorganophosphorous poisoning management in ICU
organophosphorous poisoning management in ICU
 
Drugs
DrugsDrugs
Drugs
 
Pharma intro by yousaf shah
Pharma intro by yousaf shahPharma intro by yousaf shah
Pharma intro by yousaf shah
 
Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...
Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...
Evaluation of Hepatoprotective Activity and Oxidative Stress parameters of Al...
 
L3:cholinomimetics
L3:cholinomimeticsL3:cholinomimetics
L3:cholinomimetics
 
Muhamed.k
Muhamed.kMuhamed.k
Muhamed.k
 

Javeed case presentation op poisoning

  • 1.
  • 2. Organophosphate poisoning (Ops) A CASE AND ARTICLE PRESENTATION ON
  • 3.
  • 4.
  • 5.
  • 6. Examples Examples of organophosphates include: - insecticides (malathion, parathion, diazinon, fenthion, dichlorvos, chlorpyrifos, ethion) - nerve gases (soman, sarin, tabun, VX) - ophthalmic agents (echothiophate, isoflurophate) - antihelmintics (trichlorfon). - Herbicides (tribufos [DEF], merphos) are tricresyl phosphate–containing industrial chemicals.
  • 8. Organophosphate compounds were first synthesized in the early 1800 when Lassaigne reacted alcohol with phosphoric acid. Shortly thereafter in 1854, Philip de Clermount described the synthesis of tetraethyl pyrophosphate at a meeting of the French Academy of Sciences. Eighty years later, Lange, in Berlin, and, Schrader, a chemist at Bayer AG, Germany, investigated the use of organophosphates as insecticides. History
  • 9. COVALENT BOND AGING MECHANISM OF ACTION OF ORGANOPHOSPATE POISONING 9
  • 10.
  • 12. Inhalation • Cough • Difficulty in breathing • Bronchitis • Pneumonia Eye contact • Irritation • Pain • Lacrimation • Miosis • Blurring vision • Photophobia clinical features depends on route of entry ingestion inhalation eye contact
  • 13. GASTRIC LAVAGE ACTIVATED CHARCOAL OROPHARYNGEAL AIRWAY USED AMBU VENTILATION & ET TUBE MANAGEMENT OF OP POISONING
  • 14.
  • 15.
  • 16. NAME: Mr.Krishna reddy. GENDER: MALE AGE: 33 years DEPARTMENT: General Medicine (male medical (IV) DATE OF ADMISSION: 05-02-2015. CHIEF COMPLAINTS: Vomiting present – 5 episodes. Burning sensation of throat and abdomen. HISTORY OF PRESENT ILLNESS: No h/o swelling neck and micturation present DEMOGRAPHIC DETAILS
  • 17. FAMILY HISTORY: Not relevant GENERAL EXAMINATION: PHYSICAL EXAMINATION: Conscious and oriented TEMP : Afebrile BP : 130/90 mm Hg PULSE : 124 bpm SYSTEMS EXAMINATION: CVS : S1, S2 (+) CNS : pupils-NSRL+ RS : BLAE + RR :16 cpm. P/A : soft.
  • 18. PAST MEDICAL HISTORY: not a K/c/o Diabetic, Hypertensive, Epileptic, TB. PERSONAL HISTORY AND HABITS: known alcoholic, and not a smoker. FAMILY HISTORY: Nothing is relevant. PAST SURGICAL HISTORY: No h/o previous surgery.
  • 19. PROVISIONAL DIAGNOSIS: An alleged case of op poisoning @ 7.30p.m near Badvel. ASSESSMENT ORGANOPHOSPHORUS COMPOUND POISONING
  • 20. DRUG CHART S.no DRUGS GENERIC NAME INDICATION DOSE ROA FREQUENCY DURATION 1. Inj. Atropine Atropine Antidote(anti cholinergic) 2mg (amp) IV TID 5/2/115 to 12/2/15 2. Inj. PAM Pralidoxime Antidote 1 gm (amp) IV BD 5/2/15 to 12/2/15 3. IVF Intravenous fluids Electrolyte balance 2 NS 2 RL IV INFUSION OD 9/2/15 to 12/2/15 4. Inj. Pantop Pantaprazole Anti ulcerative 40 mg IV BD 5/2/15 to 12/2/15 5. Inj. Ceftriaxone Ceftriaxone Antibacterial 1 g IV BD 5/2/15 to 9/2/15
  • 21. Progress chart PROGNOSIS TREATMENT Day 1, O/E, Pt-unconscious,vomiting BP- 130/90mmHg,PR-110bpm,RS- BLAE+, P/A-soft, CNS-NSRL+ Rx, Inj. Atropine 2 amp-IV TID in 1 NS Inj. Pantop 40mg IV BD Inj. PAM 1gm IV BD Inj. Ceftriaxone 1 gm IV BD Inj. Ondansetron 4mg IV BD Day 2, O/E, vomiting Pt is conscious, coherent, pupils- NSRL+ Rx, CST stop Inj ondansetron Day 3,O/E Pt-c/c, BP-130/80mm/Hg, PR- 110bpm Rx, CST
  • 22. Progress chart…. Day 4 , O/E, Pt- c/c, irritable, burning sensation, pupils-B/L dilated, reacting to light,BP-130/90mm Hg,PR-94bpm, Rx, CST Day 5, Pt-c/c, ↓ irritability,BP- 110/70mmHg,pupils dilated, PR- 92bpm, Rx, CST IVF 2DNS, 1RL, 1NS Day 6, Pt-general condition is fair ,C/O body pains , headache Rx, CST T.PCT 500mg BD T. Cefixime 200 mg- P/O- BD Day 7, Pt- symptomatically, BP- 120/80 mm HG, PR-90bpm, CNS-NAD, RS- Clear Rx, CST
  • 23. Progress chart… Discharge medication: Patient general condition is symptomatically better, Rx, T. B-Complex OD T. Rantac 150mg BD T. Amoxiclav 625mg BD T.PCT 500mg TID Asked to review after 1 week.
  • 24. PHARMACIST INTERVENTIONS Possible drug- drug interactions: No specific drug interactions were observed. Possible ADRs are: Atropine: Dry mouth, dysphagia, constipation, flushing, dryness of skin, palpitations Ceftriaxone: super infection, rash, fever, pruritis, nephrotoxicity Amoxyclav: GI disturbances, anaphylactic shock, pruritis, skin rashes
  • 25. PATIENT COUNSELING REGARDING DISEASE CONDITION : Organophosphorus compound poisoning is a lethal one if not treated with antidote immediately. The compound may cause respiratory depression, bradycardia, hypotension, sweating(cholinergic),unconsciousness…etc REGARDING DRUGS MEDICATION PROFILE: Inj. Atropine: Anti cholinergic drug which act as antidote for the poisoning Inj. PAM (Pralidoxime): it is an antidote. Inj. Ceftriaxone: antibacterial to treat hospital acquired infections.
  • 26. REGARDING LIFE STYLE MODIFICATIONS  Advised family to support the patient by any means  After knowing that poisoning occur ,water with mustard or water with excess salt is given and vomiting should be induced.  Referred and counseled given by psychiatrist:  The causes for suicidal attempts is to be analyzed based on that counseling is done.  To do meditation or yoga to relieve stress and to relax well  Advised him if any suicidal tendencies are seen in him, to consult a psychiatrist immediately
  • 27.
  • 28. TITLE “ INCIDENCE AND ASSESSMENT OF ANTIDOTES IN OP POISONING AT TERTIARY CARE HOSPITAL, SOUTH INDIA” Corresponding author: Daghari Zakieh Jasem, Nikitha, Rajeswari Ramaswamy, Arpan Dutta Roy, Dr. Anjani M. Reddy
  • 29. OP compounds and other pesticides are commonly used for suicide.  Globally, OP Poisoning is a major problem though its types varies in different countries. Organophosphate (OP) poisoning is always having high morbidity and mortality rates, both in poor and in well- developed countries. INTRODUCTION OP POISONING
  • 30. Major cause of morbidity and mortality is due to self- poisoning and because of their easy availability. The causes of poisoning are many-civilian, industrial, accidental & deliberate. Since the exact causative agents is not known there is a greater need for understanding the clinical characteristics of OP Poisonings.
  • 31. In the majority of situations there is a lack of analytical assistance in most of the primary health care systems. The physicians mostly depend on clinical signs and symptoms for diagnosis.  However, the toxicity might become irreversible or even fatal because onset of symptoms may take some time to develop. The Purpose of the study was to find out the incidence of OP (Organo Phosphate) poisoning cases in the ED (Emergency Department), and to assess the antidotes.
  • 32. METHODOLOGY  Study design : A Prospective observational study.  Study site :MVJ Medical College and Research Hospital,Bangalore.  Study duration : The study carried out over for 6 months.  Sample size : 90 op poisoning patients.  Inclusion criteria : OP poisoning cases in Emergency Department including casualty and ICU are included in the study.  Exclusion criteria : All other poisoning, other than OP cases, were excluded from the study.
  • 33. METHODOLOGY……… STUDY MATERIALS:  Patient demographic data collection form.  Patient informed consent form.  Case Report Form (CRF).
  • 34. ANALYSIS STATISTICAL ANALYSIS All the cases included in the study, were analyzed for the reason for Poisoning; appropriateness of gastric lavage, selection and rational use of antidotes by the investigators, using Micromedex database. DATA ANALYSIS The data including demographic information (age, sex), toxic substances involved, type of poisoning, clinical symptoms, laboratory tests and patient outcome were evaluated. Necessary steps were taken to determine the impact of clinical pharmacist involvement in poison management.
  • 36.
  • 37.
  • 38.
  • 39. CONCLUSION There are considerable variations in the practice of gastric lavage and antidote utilization in practicing clinicians in the study site. In many cases the dosing interval was wrong which lead to problems like Atropine induce Psychosis. This Study would help in prompt and appropriate poisoning treatment, and prevent the prolonged hospitalization & better patient outcome.